Skip to main content

Compassionate Wound Care®

About Us

Histologics, LLC's primary objective is to advance the field of tissue sampling into the 21st century. Proper tissue sampling and care during wound care practices should serve to save lives worldwide.

heart blue purple 350Histologics, LLC was established first as a technology incubator in 2008 out of dedication to women undergoing evaluation for abnormal cervical cancer screening and a need for better histological sampling. The founders, including Ob/Gyn inventor Dr. Neal Lonky, developed Speculoscopy (PapSure®) and SpiraBrush CX® in the 1980s and early 1990s, respectively. Years of dedication to improving healthcare led the company to innovate a different approach to obtain tissue samples.

Histologics developed a medical fabric called Kylon®, comprised of fenestrated loops that create uniquely shaped hooks woven into nylon fabric. When applied to tissue with pressure, the hooks flex downward, exposing the hook tip to the tissue face when rotated or agitated on the epithelial surface. Histological samples are both removed and stored inside the fabric. Thus, the fabric is a system comprising a tissue collection function resulting in a transepithelial biopsy sample, and a container that traps the dislodged tissue, which is stored on the device tip that is snapped free from the handle to be transported to the lab. There is no need for the clinician to handle the specimen(s) or biopsy devices, reducing the risk of contamination during the procedure and assuring the lab technicians receive the entire dislodged sample for the Pathologist's analysis after processing.

The multi-patented SoftBiopsy®, Soft K-Cot®, Soft K-Rette®, and the newly improved SoftBiopsy®+D, are distributed to physicians and licensed clinicians throughout the United States. We continually validate the quality, safety, and efficacy of our devices. More clinical trials are forthcoming. Licensed clinicians who perform wound care and are interested in evaluating the product can obtain a sample upon request. Histologics will continue to develop and innovate new products and tissue-based technologies to improve the level of care, improve the patient care experience, and help save lives worldwide. The patent portfolio for the USA and abroad is available at and other patent resources.

Division Links

 histologicsgx squarelogo22 250histologicsvt squarelogo22 250